Observational studyEuropean journal of clinical pharmacology2018

Comparative risk/benefit profile of biosimilar and originator erythropoiesis-stimulating agents (ESAs): data from an Italian observational study in nephrology.

Domenico Motola et al.PubMed ↗Publisher ↗

No numbers read from the abstract.